World's Best Scientists 2026 revealed!
Linda M. Pilarski

Linda M. Pilarski

D-Index & Metrics

Immunology

D-Index
67
Citations
14019
World Ranking
2692
National Ranking
59

Linda M. Pilarski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Linda M. Pilarski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 281 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Linda M. Pilarski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Linda M. Pilarski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Linda M. Pilarski is affiliated with the University of Alberta in Canada. Their research spans multiple intersecting fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Agricultural and Biological Sciences. These fields reflect a broad multidisciplinary approach centered on both human health and biological systems.

The main topics of their research cover areas such as Multiple Myeloma research and treatments, RNA research and splicing, peptidase inhibition and analysis, as well as studies related to Escherichia coli. Additionally, their work touches on animal disease management and epidemiology, including related research on Salmonella and Campylobacter epidemiology.

Recent publications by Linda M. Pilarski illustrate their research focus and include:

  • Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics, 2023, published in Blood Cancer Journal
  • Comparison of a Miniaturized Cassette PCR System with a Commercially Available Platform for Detecting Escherichia coli in Beef Carcass Swabs, 2021, published in Micromachines

Their frequent co-authors include:

  • Daisuke Ogiya
  • Zuzana Chyra
  • Sigitas Verselis
  • Morgan O'Keefe
  • Jacquelyn Cobb

Their work has been published primarily in venues such as Blood Cancer Journal and Micromachines, emphasizing topics in oncology, hematology, molecular biology, and agricultural science. Subfields represented in their research portfolio cover hematology, molecular biology, oncology, endocrinology, and agronomy and crop science, highlighting the diverse nature of their scientific inquiries.

Best Publications

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

    Jonathan J. Keats;Tony Reiman;Christopher A. Maxwell;Brian J. Taylor

  • In Vitro and in Vivo Targeting of Immunoliposomal Doxorubicin to Human B-Cell Lymphoma

    Lopes de Menezes De;Pilarski Lm;Allen Tm

  • Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

    J Laubach;L. Garderet;A. Mahindra;G. Gahrton

  • Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

    H M Serra;J F Krowka;J A Ledbetter;L M Pilarski

  • A High Frequency of Circulating B Cells Share Clonotypic Ig Heavy-Chain VDJ Rearrangements With Autologous Bone Marrow Plasma Cells in Multiple Myeloma, as Measured by Single-Cell and In Situ Reverse Transcriptase-Polymerase Chain Reaction

    Agnieszka J. Szczepek;Karen Seeberger;Juanita Wizniak;Michael J. Mant

  • In Multiple Myeloma, Clonotypic B Lymphocytes Are Detectable Among CD19+ Peripheral Blood Cells Expressing CD38, CD56, and Monotypic Ig Light Chain

    P L Bergsagel;A M Smith;A Szczepek;M J Mant

  • Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

    Jonathan J. Keats;Jonathan J. Keats;Jonathan J. Keats;Christopher A. Maxwell;Christopher A. Maxwell;Christopher A. Maxwell;Brian J. Taylor;Brian J. Taylor;Brian J. Taylor;Michael J. Hendzel;Michael J. Hendzel;Michael J. Hendzel

  • A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells.

    Esther G. Cen;Colin Dalton;Youlan Li;Sophia Adamia

  • Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.

    Linda M. Pilarski;Gail Hipperson;Karen Seeberger;Eva Pruski

  • Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.

    Gitte S. Jensen;Michael J. Mant;Andrew J. Belch;James R. Berenson

  • CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

    Steven P. Treon;Linda M. Pilarski;Andrew R. Belch;Abigail Kelliher

  • A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.

    Julia Kirshner;Kyle J. Thulien;Lorri D. Martin;Carina Debes Marun

  • In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]

    PL Bergsagel;AM Smith;A Szczepek;MJ Mant

  • Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone

    Steven P. Treon;Joseph A. Mollick;Mitsuyoshi Urashima;Gerrard Teoh

  • A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.

    Linda M. Pilarski

  • Receptor for Hyaluronan-Mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic Integrity

    Christopher A. Maxwell;Jonathan J. Keats;Andrew R. Belch;Linda M. Pilarski

  • Monoclonal Circulating B Cells in Multiple Myeloma: A Continuously Differentiating, Possibly Invasive, Population as Defined By Expression Of Cd45 Isoforms and Adhesion Molecules

    Linda M. Pilarski;Gitte S. Jensen

  • Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma

    Linda M. Pilarski;Andrew R. Belch

  • Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200).

    Linda M. Pilarski;Reinhard Gillitzer;Heddy Zola;Ken Shortman;Ken Shortman

  • Fluorescence Imaging of Multiple Myeloma Cells in a Clinically Relevant SCID/NOD in Vivo Model: Biologic and Clinical Implications

    Constantine S. Mitsiades;Nicholas S. Mitsiades;Ron T. Bronson;Dharminder Chauhan

Frequent Co-Authors

Steven P. Treon
Steven P. Treon Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Jason P. Acker
Jason P. Acker University of Alberta
Ian F. C. McKenzie
Ian F. C. McKenzie University of Melbourne
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Pierfrancesco Tassone
Pierfrancesco Tassone Magna Graecia University
Frederic I. Preffer
Frederic I. Preffer Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in Immunology, pursuing related online degrees can open doors to diverse healthcare careers. Many professionals transition into nursing roles, making programs like online BSN programs for non nurses an excellent starting point. These programs offer a pathway to nursing without prior clinical experience, blending foundational skills with advanced healthcare concepts.

If you're seeking a quicker route into nursing, exploring the easiest ABSN programs to get into can be beneficial. These accelerated programs are designed for individuals with previous college credits or degrees, enabling faster completion while maintaining rigorous training standards.

For those considering entry-level clinical roles, understanding which LPN programs are easiest to get into helps navigate opportunities that balance accessibility with quality education. LPNs play a critical role in patient care and can serve as a foundation for further specialization.

Finally, advancing your career as a nurse is possible through easiest online nurse practitioner programs. These degrees provide the skill set needed for autonomous practice, integrating complex immunologic and clinical knowledge to better serve patients.

Best Scientists Citing Linda M. Pilarski

Trending Scientists

Recently Published Articles